AAAAAA

   
Results: 1-10 |
Results: 10
BODY-WEIGHT DOES NOT PREDICT FOR ANTI-XA LEVELS AFTER FIXED-DOSE PROPHYLAXIS WITH ENOXAPARIN AFTER ORTHOPEDIC-SURGERY
Authors: KOVACS MJ WEIR K MACKINNON K KEENEY M BRIEN WF CRUICKSHANK MK
Citation: Mj. Kovacs et al., BODY-WEIGHT DOES NOT PREDICT FOR ANTI-XA LEVELS AFTER FIXED-DOSE PROPHYLAXIS WITH ENOXAPARIN AFTER ORTHOPEDIC-SURGERY, Thrombosis research, 91(3), 1998, pp. 137-142
3 DIFFERENT CHROMOGENIC METHODS DO NOT GIVE EQUIVALENT ANTI-XA LEVELSFOR PATIENTS ON THERAPEUTIC DALTEPARIN OR UNFRACTIONATED HEPARIN
Authors: KOVACS MJ KEENEY M MACKINNON K BOYLE E
Citation: Mj. Kovacs et al., 3 DIFFERENT CHROMOGENIC METHODS DO NOT GIVE EQUIVALENT ANTI-XA LEVELSFOR PATIENTS ON THERAPEUTIC DALTEPARIN OR UNFRACTIONATED HEPARIN, Blood, 88(10), 1996, pp. 708-708
ASSESSMENT OF APC RESISTANCE IN PATIENTS WITH CANCER WHO DEVELOP DVT
Authors: KOVACS MJ MACKINNON K KEENEY M KUMAR T BOYLE E CRUICKSHANK M
Citation: Mj. Kovacs et al., ASSESSMENT OF APC RESISTANCE IN PATIENTS WITH CANCER WHO DEVELOP DVT, Thrombosis and haemostasis, 73(6), 1995, pp. 1123-1123
DO RABBIT BRAIN-DERIVED THROMBOPLASTINS GIVE EQUIVALENT INRS FOR PATIENTS WITH LIVER-DISEASE
Authors: KOVACS MJ KEENEY M MACKINNON K WEIR K DOIG G
Citation: Mj. Kovacs et al., DO RABBIT BRAIN-DERIVED THROMBOPLASTINS GIVE EQUIVALENT INRS FOR PATIENTS WITH LIVER-DISEASE, Blood, 86(10), 1995, pp. 3495-3495
THE RESPONSE TO ACTIVATED PROTEIN-C (APC) DIFFERENT BETWEEN HEALTHY-MEN AND WOMEN
Authors: KOVACS MJ KEENEY M WEIR K MACKINNON K
Citation: Mj. Kovacs et al., THE RESPONSE TO ACTIVATED PROTEIN-C (APC) DIFFERENT BETWEEN HEALTHY-MEN AND WOMEN, Blood, 86(10), 1995, pp. 3496-3496
ASSESSMENT OF APC RESISTANCE IN PATIENTS WITH CANCER WHO DEVELOP DVT - AN UPDATE
Authors: KOVACS MJ MACKINNON K KEENEY M WONG L KUMAR T MORROW B CRUICKSHANK M
Citation: Mj. Kovacs et al., ASSESSMENT OF APC RESISTANCE IN PATIENTS WITH CANCER WHO DEVELOP DVT - AN UPDATE, Blood, 86(10), 1995, pp. 3660-3660
BODY-WEIGHT AND ANTI-XA LEVELS DO NOT PREDICT FOR VENOUS THROMBOEMBOLIC DISEASE (VTE) AFTER LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) PROPHYLAXISFOLLOWING ORTHOPEDIC-SURGERY
Authors: KOVACS MJ CRUICKSHANK M MACKINNON K WEIR K KEENEY M VONLEWINSKI M MORROW B PALMER B BRIEN WF
Citation: Mj. Kovacs et al., BODY-WEIGHT AND ANTI-XA LEVELS DO NOT PREDICT FOR VENOUS THROMBOEMBOLIC DISEASE (VTE) AFTER LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) PROPHYLAXISFOLLOWING ORTHOPEDIC-SURGERY, Blood, 86(10), 1995, pp. 3661-3661
ASSESSMENT OF THE VALIDITY OF THE INR SYSTEM FOR PATIENTS WITH LIVER IMPAIRMENT
Authors: KOVACS MJ WONG A MACKINNON K WEIR K KEENEY M BOYLE E CRUICKSHANK M
Citation: Mj. Kovacs et al., ASSESSMENT OF THE VALIDITY OF THE INR SYSTEM FOR PATIENTS WITH LIVER IMPAIRMENT, Thrombosis and haemostasis, 71(6), 1994, pp. 727-730
AN INTEREST-RATE PEG, INFLATION AND OUTPUT
Authors: MACKINNON K SMITHIN J
Citation: K. Mackinnon et J. Smithin, AN INTEREST-RATE PEG, INFLATION AND OUTPUT, Journal of macroeconomics, 15(4), 1993, pp. 769-785
IS THE INR VALID FOR PATIENTS WITH LIVER IMPAIRMENT
Authors: KOVACS MJ WONG A MACKINNON K WEIR K KEENEY M BOYLE E CRUICKSHANK M
Citation: Mj. Kovacs et al., IS THE INR VALID FOR PATIENTS WITH LIVER IMPAIRMENT, Blood, 82(10), 1993, pp. 10000595-10000595
Risultati: 1-10 |